JRSIS Health Care Corporation (JRSS)
USD 0.03
(0.0%)
USD 0.03
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 483.05 Thousand USD | 103.3% |
| 2022 | -14.62 Million USD | -160.44% |
| 2021 | 24.19 Million USD | 17.61% |
| 2020 | 20.57 Million USD | 8.52% |
| 2019 | 18.95 Million USD | 17.03% |
| 2018 | 16.19 Million USD | 13.75% |
| 2017 | 14.24 Million USD | 23.95% |
| 2016 | 11.48 Million USD | 49.17% |
| 2015 | 7.7 Million USD | 103.05% |
| 2014 | 3.79 Million USD | 35.66% |
| 2013 | 2.79 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 186.11 Thousand USD | 225.25% |
| 2024 Q1 | 57.22 Thousand USD | -86.57% |
| 2023 Q2 | 40.14 Thousand USD | -91.5% |
| 2023 Q4 | 426.16 Thousand USD | 4096.21% |
| 2023 FY | 483.05 Thousand USD | 103.3% |
| 2023 Q3 | 10.15 Thousand USD | -74.7% |
| 2023 Q1 | 472.19 Thousand USD | 105.67% |
| 2022 Q3 | -2166.00 USD | -43.92% |
| 2022 Q2 | -1505.00 USD | -100.02% |
| 2022 Q1 | 9.32 Million USD | 42.6% |
| 2022 FY | -14.62 Million USD | -160.44% |
| 2022 Q4 | -8.33 Million USD | -384487.03% |
| 2021 Q4 | 6.54 Million USD | 6.9% |
| 2021 Q2 | 6.63 Million USD | 35.63% |
| 2021 FY | 24.19 Million USD | 17.61% |
| 2021 Q3 | 6.11 Million USD | -7.85% |
| 2021 Q1 | 4.89 Million USD | -34.46% |
| 2020 Q1 | 3.83 Million USD | -28.28% |
| 2020 Q2 | 3.9 Million USD | 1.97% |
| 2020 Q3 | 5.36 Million USD | 37.36% |
| 2020 Q4 | 7.46 Million USD | 39.19% |
| 2020 FY | 20.57 Million USD | 8.52% |
| 2019 FY | 18.95 Million USD | 17.03% |
| 2019 Q1 | 4.28 Million USD | 5.49% |
| 2019 Q4 | 5.34 Million USD | 13.39% |
| 2019 Q2 | 4.62 Million USD | 7.85% |
| 2019 Q3 | 4.71 Million USD | 1.94% |
| 2018 Q4 | 4.06 Million USD | 6.72% |
| 2018 FY | 16.19 Million USD | 13.75% |
| 2018 Q3 | 3.8 Million USD | -7.97% |
| 2018 Q2 | 4.13 Million USD | -1.43% |
| 2018 Q1 | 4.19 Million USD | -0.18% |
| 2017 Q1 | 3.3 Million USD | 6.36% |
| 2017 FY | 14.24 Million USD | 23.95% |
| 2017 Q4 | 4.2 Million USD | 20.03% |
| 2017 Q3 | 3.5 Million USD | 8.27% |
| 2017 Q2 | 3.23 Million USD | -2.06% |
| 2016 FY | 11.48 Million USD | 49.17% |
| 2016 Q2 | 2.75 Million USD | -5.29% |
| 2016 Q3 | 2.71 Million USD | -1.68% |
| 2016 Q4 | 3.1 Million USD | 14.46% |
| 2016 Q1 | 2.91 Million USD | 15.68% |
| 2015 Q1 | 1.57 Million USD | 57.7% |
| 2015 Q4 | 2.51 Million USD | 36.0% |
| 2015 Q3 | 1.85 Million USD | 5.22% |
| 2015 Q2 | 1.75 Million USD | 11.92% |
| 2015 FY | 7.7 Million USD | 103.05% |
| 2014 Q3 | 848.75 Thousand USD | -13.34% |
| 2014 FY | 3.79 Million USD | 35.66% |
| 2014 Q4 | 997.06 Thousand USD | 17.47% |
| 2014 Q2 | 979.44 Thousand USD | 1.22% |
| 2014 Q1 | 967.65 Thousand USD | 21.36% |
| 2013 Q1 | 448.23 Thousand USD | 0.0% |
| 2013 Q2 | 464.69 Thousand USD | 3.67% |
| 2013 Q3 | 645.36 Thousand USD | 38.88% |
| 2013 FY | 2.79 Million USD | 0.0% |
| 2013 Q4 | 797.33 Thousand USD | 23.55% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| The Amacore Group, Inc. | 9.39 Million USD | 94.86% |
| Arem Pacific Corporation | 239.16 Thousand USD | -101.976% |
| Assisted 4 Living, Inc. | 712.32 Thousand USD | 32.187% |
| BioCorRx Inc. | 53.17 Thousand USD | -808.435% |
| Bionik Laboratories Corp. | 989.87 Thousand USD | 51.201% |
| Banyan Corp. | 5 Million USD | 90.346% |
| Clearday, Inc. | -6.84 Million USD | 107.052% |
| Dental Patient Care America, Inc. | 3.24 Million USD | 85.111% |
| Quantum Medical Transport, Inc. | 1097.61 USD | -43909.348% |
| Empower Clinics Inc. | 1.96 Million USD | 75.455% |
| First Choice Healthcare Solutions, Inc. | -12.19 Thousand USD | 4060.733% |
| Selectis Health, Inc. | 5.4 Million USD | 91.066% |
| Ethema Health Corporation | 4.66 Million USD | 89.654% |
| HealthLynked Corp. | 2.34 Million USD | 79.434% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 6.78 Million USD | 92.88% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 143.69 Million USD | 99.664% |
| MedSmart Group Inc. | -19.03 Thousand USD | 2637.299% |
| North America Frac Sand, Inc. | 73.25 Thousand USD | -559.401% |
| Nova Leap Health Corp. | 9.76 Million USD | 95.055% |
| Nexteligent Holdings, Inc. | 351.66 Thousand USD | -37.362% |
| PAO Group, Inc. | - USD | -Infinity% |
| Primemd Inc. | 10.5 Million USD | 95.4% |
| Raffles Medical Group Ltd | 239.4 Million USD | 99.798% |
| Ryman Healthcare Limited | 260.65 Million USD | 99.815% |
| Stem Cell Authority, Ltd. | - USD | -Infinity% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | -1.21 Million USD | 139.88% |
| Mycotopia Therapies, Inc. | -61.21 Thousand USD | 889.08% |
| U.S. NeuroSurgical Holdings, Inc. | -20 Thousand USD | 2515.255% |
| Veltex Corporation | 694.58 Thousand USD | 30.455% |
| World Financial Holding Group | - USD | -Infinity% |
| Xcelerate Inc. | 294.11 Thousand USD | -64.238% |